Abstract
Unlike other food allergies commonly seen in childhood, peanut allergy is often severe and life-long. The current literature on pediatric peanut allergy focuses on the increasing prevalence, risk factors, genetics and clinical characteristics. Diagnosis of clinically-relevant peanut allergy involves the combination of patient history with testing for the presence of peanut-specific IgE. There is currently no available cure for food allergy, so primary therapy concentrates on the prevention of exposure to peanut and readiness to manage a reaction. Life-saving treatment of anaphylaxis secondary to accidental peanut exposure involves immediate epinephrine injection. Future research will involve the generation of novel therapeutic approaches including immunotherapy and vaccinations, which will hopefully improve the quality of life for peanut-allergic patients and their families. This article reviews the latest reported findings and ongoing scientific research on these topics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.